---
title: Dr Nir Barzilai and the TAME study
videoId: sFbghkE0WYo
---

From: [[⁨cleoabram⁩]] <br/> 

Dr. Nir Barzilai is a leading expert on aging research, particularly focusing on the potential of existing drugs like metformin to delay the effects of aging <a class="yt-timestamp" data-t="01:09:23">[01:09:23]</a>. His work challenges traditional views on age-related diseases, suggesting that aging itself is the primary driver of these conditions <a class="yt-timestamp" data-t="01:51:36">[01:51:36]</a>.

## Re-evaluating Anti-Aging

Historically, the concept of "anti-aging" has been associated with questionable practices and "charlatans" selling "snake oil" <a class="yt-timestamp" data-t="00:52:30">[00:52:30]</a>. Dr. Barzilai clarifies that modern scientific anti-aging research is not about discovering a "fountain of youth" or making old people young <a class="yt-timestamp" data-t="01:15:30">[01:15:30]</a>. Instead, the goal is to delay the harmful effects of aging, specifically the increased risk of death from common diseases like cancer, heart disease, and Alzheimer's <a class="yt-timestamp" data-t="01:30:30">[01:30:30]</a>.

The premise is that bodies accumulate damage over time, and the diseases humans die from often stem from this damage <a class="yt-timestamp" data-t="02:02:30">[02:02:30]</a>. If this accumulation of damage could be delayed, the onset of these diseases could also be pushed back, potentially extending lifespan <a class="yt-timestamp" data-t="02:16:30">[02:16:30]</a>.

## Metformin: A Potential Anti-Aging Drug

Metformin is an inexpensive, generic drug that has been used effectively for decades by people with diabetes to control blood sugar levels <a class="yt-timestamp" data-t="00:20:30">[00:20:30]</a>. Recently, it has gained popularity among wealthy individuals for its perceived anti-aging benefits <a class="yt-timestamp" data-t="00:31:30">[00:31:30]</a>.

### Key Study Findings

In 2014, Dr. Barzilai encountered a significant UK study involving approximately 180,000 people <a class="yt-timestamp" data-t="02:23:30">[02:23:30]</a>. This retrospective study compared three groups:
*   People with diabetes taking metformin <a class="yt-timestamp" data-t="02:36:30">[02:36:30]</a>
*   People with diabetes taking other drugs not metformin <a class="yt-timestamp" data-t="02:40:30">[02:40:30]</a>
*   People without diabetes not taking any diabetes drugs <a class="yt-timestamp" data-t="02:45:30">[02:45:30]</a>

The study found that people with diabetes *not* taking metformin had double the mortality rate compared to people without diabetes <a class="yt-timestamp" data-t="02:47:30">[02:47:30]</a>. Crucially, diabetics taking metformin, despite being more obese and sick initially, had *less* mortality than people without diabetes <a class="yt-timestamp" data-t="02:54:30">[02:54:30]</a>. This finding—that diabetics on metformin died less than people without diabetes—was considered "HUGE" <a class="yt-timestamp" data-t="03:08:30">[03:08:30]</a>.

### [[Current research on metformin and its limitations | Limitations of Existing Research]]

Despite promising correlations, there are significant caveats:
*   **Correlation vs. Causation:** The 2014 UK study was retrospective, meaning it looked back at existing data and could not establish that metformin *caused* the reduced mortality <a class="yt-timestamp" data-t="03:19:30">[03:19:30]</a>.
*   **Diabetic Population:** All participants taking metformin in this study had diabetes <a class="yt-timestamp" data-t="03:27:30">[03:27:30]</a>. It is currently unclear if the "dying less" effect applies to individuals without diabetes <a class="yt-timestamp" data-t="03:31:30">[03:31:30]</a>.
*   **Mechanism of Action:** While metformin's mechanism in controlling blood sugar for diabetics is well-understood <a class="yt-timestamp" data-t="03:40:30">[03:40:30]</a>, its potential anti-aging mechanism in non-diabetics is much less known <a class="yt-timestamp" data-t="03:56:30">[03:56:30]</a>. The lack of incentive for pharmaceutical companies to fund expensive research on a cheap generic drug also limits new studies <a class="yt-timestamp" data-t="04:03:30">[04:03:30]</a>.
*   **Animal Studies:** Other studies have shown anti-aging effects of metformin in healthy mice and worms <a class="yt-timestamp" data-t="04:12:30">[04:12:30]</a>, but human trials are needed to confirm these effects.

## The TAME Study

To address these limitations, Dr. Barzilai is leading a new nationwide study called TAME, which stands for **Targeting Aging with Metformin** <a class="yt-timestamp" data-t="04:36:30">[04:36:30]</a>. This will be a randomized trial where half the participants receive metformin and half receive a placebo <a class="yt-timestamp" data-t="04:29:30">[04:29:30]</a>.

The primary objective of the TAME study is to present data to the FDA to potentially repurpose metformin as a drug that explicitly targets aging <a class="yt-timestamp" data-t="04:48:30">[04:48:30]</a>. If successful, this would be a monumental achievement, potentially offering an affordable way to delay the accumulation of damage and the progression of diseases that kill millions globally, such as heart disease (18 million deaths/year), cancer (10 million deaths/year), and Alzheimer's (55 million people affected) <a class="yt-timestamp" data-t="05:01:30">[05:01:30]</a>.

## Personal Considerations for Taking Metformin

For individuals considering taking metformin for anti-aging purposes *before* the TAME trial results are available, the decision typically involves weighing three factors <a class="yt-timestamp" data-t="05:44:30">[05:44:30]</a>:
1.  **Assessment of Existing Studies:** Evaluating the current evidence, acknowledging its limitations <a class="yt-timestamp" data-t="05:52:30">[05:52:30]</a>.
2.  **Perceived Urgency of Aging:** A personal choice regarding how pressing the issue of aging feels <a class="yt-timestamp" data-t="05:57:30">[05:57:30]</a>.
3.  **Benefits vs. Side Effects:** Considering potential benefits against known side effects <a class="yt-timestamp" data-t="06:03:30">[06:03:30]</a>.

### Side Effects of Metformin

Common side effects in the first week of use include early satiety (not feeling hungry), upset stomach, and diarrhea <a class="yt-timestamp" data-t="06:07:30">[06:07:30]</a>. Metformin also impacts the body's response to exercise; while muscle capacity will still increase with exercise, the muscles may not grow as large <a class="yt-timestamp" data-t="06:20:30">[06:20:30]</a>.

Individuals currently taking metformin off-label for anti-aging without diabetes are making a calculation based on their satisfaction with existing studies, tolerance for side effects, and a personal sense of urgency regarding aging <a class="yt-timestamp" data-t="06:51:30">[06:51:30]</a>. However, experts emphasize the importance of waiting for more definitive studies like TAME before considering such medication <a class="yt-timestamp" data-t="07:10:30">[07:10:30]</a>.